l.pires

TL2 · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 19 February 2025 · last posted 3d · groups: regional-na

83 posts, newest first. Showing up to 150.

Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #95 · Practice › Dosing & titration · 25 Jul 2026 · 4 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #13 · Compounds › Tirzepatide · 21 Jul 2026 · 0 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
Which categories are strict and which are relaxed, honestly Replied, post #24 · Start Here › Welcome · 17 Jul 2026 · 2 likes One small courtesy that makes a large difference: put the specific question in the title. It is the single thing that most changes how quickly you get a useful reply.…
Common supplements people ask about, assessed one at a time Replied, post #56 · Practice › Interactions · 16 Jul 2026 · 25 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
Blinding yourself: practical methods and their limits — the long version Replied, post #10 · Research Methods › N-of-1 designs · 16 Jul 2026 · 18 likes The best thing about this subcategory is that people post their protocols before their results. That order is what keeps it honest. That is my reading. Someone else…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #32 · Access › Insurance & coverage · 15 Jul 2026 · 3 likes Narrowing post #31, because the general version has more than one answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #82 · Analytics › Home & field testing · 13 Jul 2026 · 0 likes Adding the measurement that post #79 says would settle it. The honest cost comparison is a home kit against a single independent submission. For most people the second…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #15 · Practice › Interactions · 11 Jul 2026 · 8 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. Delayed gastric emptying is the mechanism behind most of the…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #38 · Evidence › Journal club · 8 Jul 2026 · 15 likes The claim about SUSTAIN 6 upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
A structured critique template this community uses — a second dataset Replied, post #30 · Evidence › Study critique · 6 Jul 2026 · 4 likes Everything in post #26 holds. The case it does not cover is the one I have. On structured critique template the community has more anecdote than the confidence in this…
Tracking a shortage from primary sources rather than rumour Replied, post #84 · Access › Shortages · 4 Jul 2026 · 9 likes Post #81 is the version of this I will quote in future. One addition. International supply chains: a shortage in one country does not mean shortage in another. That is…
Alcohol: what is documented and what is folklore Replied, post #84 · Practice › Interactions · 30 Jun 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Insurance and replacement policies, compared Replied, post #49 · Sourcing › Logistics · 28 Jun 2026 · 5 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
Request: tag synonyms surfaced in search Replied, post #6 · Meta › Feature requests · 25 Jun 2026 · 8 likes A request rather than an answer: could whoever has the primary source for tag synonyms surfaced in search post it? I have seen the claim three times this month and each…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #11 · Analytics › Mass spectrometry · 21 Jun 2026 · 0 likes Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide can look busier than expected. Not a strong opinion,…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #113 · Practice › Storage & stability · 9 Jun 2026 · 1 like Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
Revisiting: Mean kinetic temperature explained without the mathematics Started this topic · Practice › Storage & stability · 29 May 2026 · 0 likes Revisiting: Mean kinetic temperature explained without the mathematics Writing it up because I had to work it out twice and would rather nobody else did. A methods…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #3 · Evidence › Journal club · 26 May 2026 · 28 likes Helpful, and short, which on this subject is harder than long.
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #30 · Practice › Storage & stability · 16 May 2026 · 0 likes Answering the question post #27 raises rather than the one it answers. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
Follow-up: Sleep quality changes during weight loss Replied, post #17 · Wellbeing › Sleep · 6 May 2026 · 3 likes Energy availability affects sleep in both directions, and a large deficit can produce either fragmentation or unusual sleepiness. This is the version I would want a new…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #120 · Practice › Reconstitution · 25 Apr 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Follow-up: State-level differences that actually matter Replied, post #81 · Regional › North America · 8 Apr 2026 · 24 likes Post #77 describes the usual case. This is about the unusual one. Compounded preparations and authorised products are different regulatory categories with different…
Follow-up: Sleep quality changes during weight loss Replied, post #2 · Wellbeing › Sleep · 7 Apr 2026 · 27 likes Where sleep worsened at the same time as an escalation and improved afterwards, that sequence is worth recording rather than reasoning about.
Choosing which test to pay for, given a fixed budget Replied, post #50 · Sourcing › Independent verification · 2 Apr 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. That is all the detail I have. Someone…
A site rotation scheme that is easy enough to actually follow Replied, post #24 · Practice › Administration · 21 Mar 2026 · 0 likes Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area repeatedly is worth a change of technique or of site rather…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #92 · Access › Pricing · 17 Feb 2026 · 0 likes I had written a reply contradicting post #88 and deleted it. Here is what survived. Price variation between pharmacies: identical prescriptions can cost different…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #54 · Outcomes › Progress reports · 14 Feb 2026 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
MHRA statements, read directly Replied, post #88 · Regional › UK & Ireland · 13 Feb 2026 · 0 likes Post #87 answers the question as asked. The question underneath it is different. I have been on both sides of the MHRA statements argument in this category within…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #85 · Wellbeing › Mental health · 1 Feb 2026 · 29 likes I would call the community position on Anxiety likely rather than established, and I would be comfortable defending that hedge.
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #66 · Clinical › Special populations · 2 Jan 2026 · 0 likes What would change my mind on older adults is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #78 · Practice › Interactions · 28 Dec 2025 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #16 · Access › International · 18 Dec 2025 · 2 likes The bit of Language barriers in accessing that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #4 · marked as the solution · Analytics › COA interpretation · 5 Dec 2025 · 18 likes I read the earlier replies on Reused chromatograms across lots twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #41 · Compounds › Semaglutide · 5 Dec 2025 · 0 likes Before the thread moves on from semaglutide solutions — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
Tracking a preprint to publication: a worked example Replied, post #50 · Evidence › Preprints · 5 Dec 2025 · 32 likes The question underneath tracking a preprint is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #25 · Data & Tools › Calculators · 2 Dec 2025 · 0 likes Post #21 and I disagree about the size of the effect, not about the direction. Practical answer on Feature request, since the theoretical one is upthread: do the…
Second pass at: The mass-error checker and its intended scope Replied, post #70 · Data & Tools › Calculators · 22 Nov 2025 · 33 likes Practical experience of mass-error checker, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Thyroid function tests during substantial weight change Replied, post #121 · Clinical › Bloodwork · 4 Nov 2025 · 23 likes I had written a reply contradicting post #120 and deleted it. Here is what survived. Repeat before acting is standard practice for an isolated abnormal result on most…
Can a home kit substitute for a laboratory report? A careful no Replied, post #44 · Analytics › Home & field testing · 2 Nov 2025 · 20 likes The honest answer on home kit substitute is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.…
Reading a supplier's product description as a marketing document Replied, post #90 · Compounds › Other compounds · 28 Oct 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Managing an unplanned gap in supply — what changed since Replied, post #90 · Access › Shortages · 17 Oct 2025 · 0 likes Everything in post #88 holds. The case it does not cover is the one I have. The reason Managing an unplanned gap keeps being re-asked is that the answer is conditional…
Publishing an inconvenient result: a case study — the long version Replied, post #8 · Sourcing › Independent verification · 12 Oct 2025 · 10 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #144 · Data & Tools › Calculators · 8 Oct 2025 · 8 likes A request rather than an answer: could whoever has the primary source for titration planner refuses post it? I have seen the claim three times this month and each…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Started this topic · Compounds › Semaglutide · 26 Sep 2025 · 54 likes On the subject in the title: Semaglutide in people without diabetes: what the evidence base looks like Working notes rather than a conclusion. Two things I would like…
What a purity-only report leaves out Replied, post #22 · Sourcing › Independent verification · 22 Sep 2025 · 10 likes Coming back to post #20, because the follow-up matters more than the original answer. Repeat determination on the same product line months apart is the measurement that…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #73 · Evidence › Journal club · 3 Sep 2025 · 25 likes Where I part company with post #71, and it is a narrow parting. Bringing the previous paper on the same question makes the session much better and doubles the…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #11 · Sourcing › Regulatory · 19 Aug 2025 · 3 likes Where I have landed on compound being unapproved, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
What I would record differently if I started again — the long version Replied, post #7 · Outcomes › Progress reports · 15 Aug 2025 · 2 likes This is the first time the answer has come with its own limits attached. Appreciated.
Asking about a compound your prescriber has not heard of Replied, post #114 · Clinical › Prescriber conversations · 3 Aug 2025 · 3 likes Asking what would change the plan is more productive than asking whether the plan is right. It gets you the decision criteria rather than a verdict. Scoping that to…
Are there stupid questions here? A staff answer, at length Replied, post #20 · Start Here › Welcome · 28 Jul 2025 · 29 likes Agreed, and I will stop repeating the version of this I had been repeating.
Coming back to: What published stability data actually covers, and what it does not Replied, post #82 · Practice › Storage & stability · 8 Jul 2025 · 2 likes Room-temperature stability claims for licensed products in this class are specific about duration and about whether the period is cumulative. Cumulative is the word…
Research-use-only labelling: what it means and what it does not Replied, post #9 · Sourcing › Regulatory · 6 Jul 2025 · 2 likes A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable. That is the version I use. It may…
Repeatability versus intermediate precision Replied, post #120 · Analytics › Method validation · 2 Jul 2025 · 26 likes Adding the measurement that post #118 says would settle it. System suitability: injections run at the start of a batch to establish that the instrument and column are…
[2026 update] An appeal that failed, and what I would do differently Replied, post #72 · Access › Insurance & coverage · 11 Jun 2025 · 22 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #27 · Evidence › Journal club · 5 Jun 2025 · 29 likes This is the first time the answer has come with its own limits attached. Appreciated.
Risk-of-bias tools and the judgement they conceal Replied, post #3 · Evidence › Meta-analyses · 21 May 2025 · 4 likes The opening post describes the usual case. This is about the unusual one. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
Pregnancy as an absolute contraindication Replied, post #98 · Safety › Contraindications · 20 May 2025 · 5 likes A rodent toxicology finding underlying a contraindication is worth understanding, because it explains why the contraindication is narrow rather than broad. I am…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #51 · Sourcing › Independent verification · 5 May 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Follow-up: Documentation that appears only after payment Replied, post #24 · Sourcing › Red flags · 26 Apr 2025 · 4 likes Everything in post #20 holds. The case it does not cover is the one I have. A stock listing that never changes and a lead time that never varies are both worth…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #98 · Evidence › Journal club · 21 Apr 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #4 · Analytics › Method validation · 20 Apr 2025 · 10 likes The opening post is right about the mechanism and I think understates the practical bit. The most useful single question about a method: what would it fail to detect?…
Follow-up: What other technical communities get right that we do not Replied, post #62 · Lounge › Off topic · 9 Apr 2025 · 1 like That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #39 · Clinical › Comorbidities · 22 Mar 2025 · 30 likes An honest declaration on obstructive sleep apnoea: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #107 · Access › International · 18 Mar 2025 · 2 likes On Cross-border purchase within: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
Charge states for a 4 kDa peptide, worked through Replied, post #130 · Analytics › Mass spectrometry · 17 Mar 2025 · 0 likes Picking up post #129: that is the part I would want checked first. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057,…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #38 · Compounds › Semaglutide · 13 Mar 2025 · 21 likes Reading this SELECT thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Second pass at: Pen dose counters: what a click does and does not guarantee Started this topic · Devices › Pens & autoinjectors · 12 Mar 2025 · 33 likes Second pass at: Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. Two things I would…
Charge states for a 4 kDa peptide, worked through Replied, post #50 · Analytics › Mass spectrometry · 8 Mar 2025 · 21 likes Where I part company with post #48, and it is a narrow parting. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because…
Validating a method you did not develop — does this still hold? Replied, post #42 · Analytics › Method validation · 24 Feb 2025 · 18 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #23 · Practice › Reconstitution · 30 Jan 2025 · 14 likes Post #20 is right about the mechanism and I think understates the practical bit. Reconstituting the whole vial when you will use a quarter of it is a decision to store…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #5 · Practice › Dosing & titration · 22 Jan 2025 · 0 likes Two questions I would want answered before drawing anything from the Escalating every six weeks instead data above: how were the cases selected, and what happened to…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #93 · Compounds › Tirzepatide · 17 Dec 2024 · 1 like Confirming post #90 from a second method, which matters more than confirming it from a second person. Comparisons between the tirzepatide and semaglutide programmes…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 7 Dec 2024 · 30 likes I had read the opposite somewhere and cannot now find where, which tells me something.
A promotion I argued against, and why I lost Replied, post #11 · Documentation › Doc review · 22 Nov 2024 · 0 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage.
EMA product information as a primary source — does this still hold? Replied, post #13 · Regional › European Union · 14 Nov 2024 · 10 likes Source for the EMA product information figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
Second pass at: Gauge and length selection for subcutaneous injection Started this topic · Devices › Syringes & needles · 8 Nov 2024 · 4 likes Posting this under the heading it deserves: Second pass at: Gauge and length selection for subcutaneous injection Everything below is what sits behind that. The…
When a red flag was a misunderstanding, and the retraction Replied, post #35 · Sourcing › Red flags · 16 Oct 2024 · 7 likes On post #31 — agreed on the reasoning, with one qualification. A stock listing that never changes and a lead time that never varies are both worth noticing. Real…
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #6 · Compounds › Secretagogues & GH axis · 12 Oct 2024 · 11 likes Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone releasing hormone receptor rather than supplying growth hormone, which is the…
Blind submission and why it changes minds Replied, post #63 · Sourcing › Independent verification · 17 Sep 2024 · 22 likes Agreed, and I will stop repeating the version of this I had been repeating.
Circumference measurements as a poor man's composition estimate Replied, post #37 · Outcomes › Body composition · 2 Aug 2024 · 0 likes Worth separating two things that post #35 runs together. Bone mineral density changes with substantial weight loss are measurable and slow, and are one of the better…
Guidelines revision: what changed and why Replied, post #86 · Meta › Announcements · 27 Jul 2024 · 22 likes The version of guidelines revision that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds,…
How to ask for a dose change without antagonising anyone Replied, post #2 · Clinical › Prescriber conversations · 30 Jun 2024 · 0 likes Narrowing the opening post, because the general version has more than one answer. Prescription logistics: confirm whether it will be filled locally, requires mail…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #9 · Practice › Dosing & titration · 5 Jun 2024 · 19 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.